Combo Panel – (Comprehensive Panel+ Weight Loss)-Important Research

Personalized therapy for cardiovascular disease

Researchers have announced results showing that patients with cardiovascular disease and the appropriate genetic background benefit greatly from the new medication dalcetrapib, with a reduction of 39 percent in combined clinical outcomes including heart attacks, strokes, unstable angina, coronary revascularizations and cardiovascular deaths. These patients also benefit from a reduction in the amount of atherosclerosis in their vessels. This discovery may also pave the way for a new era in cardiovascular medicine, with personalized or precision drugs.

Genes influence response to glycemic control as a preventive therapy for cardiovascular complications in type 2 diabetes

Genes play a role in how people with type 2 diabetes at high risk of cardiovascular disease risk respond to intensive glycemic control as an intervention to prevent the disease.

Some ‘healthy’ vegetable oils may actually increase risk of heart disease

Some vegetable oils that claim to be healthy may actually increase the risk of heart disease, and health officials should reconsider cholesterol-lowering claims on food labelling, states an analysis.